Maxcyte (MXCT) Capital Expenditures (2020 - 2026)
Maxcyte (MXCT) posted quarterly Capital Expenditures of $72000.0 for Q1 2026, down 88.97% year-over-year from $653000.0 in Q1 2025, and up 136.0% quarter-over-quarter from -$200000.0 in Q4 2025.
Maxcyte (MXCT) Capital Expenditures (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Capital Expenditures for 7 consecutive years, with $72000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 88.97% year-over-year to $72000.0; the TTM figure through Mar 2026 stood at $143000.0 (down 81.74% YoY), while the FY2025 annual figure was $724000.0, up 646.39% from the prior year.
- Capital Expenditures grew to $72000.0 in Q1 2026 per MXCT's latest filing, from -$200000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $17.6 million in Q4 2022 and bottomed at -$5.4 million in Q2 2022.
- Historically, Capital Expenditures has averaged $1.2 million across 5 years, with a median of $72000.0 in 2026.
- Annual changes were most pronounced in 2022 — Capital Expenditures jumped 12118.94% — and 2025, when it tumbled 595.56%.
- Maxcyte's Capital Expenditures stood at $17.6 million in 2022, then sank by 112.61% to -$2.2 million in 2023, then jumped by 102.79% to $62000.0 in 2024, then plunged by 422.58% to -$200000.0 in 2025, then soared by 136.0% to $72000.0 in 2026.
- Business Quant data shows MXCT's Capital Expenditures at $72000.0 in Q1 2026, -$200000.0 in Q4 2025, and -$313000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Maxcyte | 148.48 Mn | 148.48 Mn | 5.60 Mn | -1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.58 Mn |
| Jun 30, 2026 | -1.58 Mn |
| Mar 31, 2026 | 72,000.00 |
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | -200,000.00 |
| Dec 31, 2025 | -200,000.00 |
| Sep 30, 2025 | -313,000.00 |
| Sep 30, 2025 | -313,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Mar 31, 2025 | 653,000.00 |
| Mar 31, 2025 | 653,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Jun 30, 2024 | 113,000.00 |
| Jun 30, 2024 | 113,000.00 |
| Mar 31, 2024 | -33,000.00 |
| Mar 31, 2024 | -33,000.00 |